Vesibax

N/A

Report date: 2024/01/09 15:38:27

Base Information

Drug NameVesibax
Drug Alias NameBladder cancer therapeutic (Prokarium)ZH-9ZH9
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProkarium Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProkarium Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A